Asynt

Activities: Manufacturing Analysis

Trending Articles

  1. NICE approves KEYTRUDA as first perioperative immunotherapy for locally advanced head and neck cancer MSD's KEYTRUDA (pembrolizumab) has received NICE approval as a neoadjuvant and adjuvant therapy for resectable LA HNSCC—the first immunotherapy recommended in this...
  2. Destination Russia for new NYK Logistics warehouse Logistics specialist NYK is expanding its market presence with the launch of new warehousing operation in Moscow, Russia.
  3. Pfizer agrees sale of consumer healthcare business to J&J Pfizer Inc has reached an agreement to sell its consumer healthcare business to Johnson & Johnson (J&J) for US$16.6bn (euro13.2bn) in cash.
  4. Pfizer's HYMPAVZI receives positive CHMP opinion for haemophilia A and B patients with inhibitors The EMA's Committee for Medicinal Products for Human Use has recommended expanding the approved indication for Pfizer's HYMPAVZI to include adolescents and adults with...
  5. AstraZeneca's tozorakimab meets primary endpoint in both Phase III COPD trials AstraZeneca has reported positive results from the OBERON and TITANIA Phase III trials, with tozorakimab significantly reducing moderate-to-severe COPD exacerbations compared...

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Eight reactions. One platform. Faster discovery at Heriot-Watt

The Donnelly Research Group at Heriot-Watt University (Edinburgh, UK) has published a compelling case study highlighting significant operational and scientific advantages when performing parallel inert chemistry using the DrySyn OCTO 8-position Reaction Station, a compact benchtop synthesis platform developed by Asynt
Ingredients

Lighthouse photoreactor module expands Integrity 10 platform for controlled, high-throughput photochemistry

New module enables parallel photochemistry with precise reaction control and flexible LED options
Manufacturing

Expansion of oil-free parallel stirring platform enhances reaction screening

Asynt improves DrySyn Vortex system to support standard glassware and simultaneous multi-flask stirring
Drug Delivery

Photocatalysed flow method accelerates synthesis of potent MC4R antagonist

New automated continuous flow synthesis of spirocyclic tetrahydronaphthyridines for drug discovery
Drug Delivery

Modular automated flow synthesis of spirocyclic THNs from primary alkylamines

Asynt and the Cresswell Group achieve advances in drug discovery scaffolds
Manufacturing

Triple your efficiency with the new DrySyn Vortex

Boost productivity with temperature-controlled parallel reactions
Hi Tech Manufacturing

Asynt announces new range of photochemistry reactors

The laboratory specialis's new collection of reactors form part of their broad catalogue of both batch and flow equipment which enable flexible use for chemists over a wide range of applications and scales
Subscribe now